Topics
ONE TIME EVENT
Beyond Conventional: The New Horizon of Immunotherapy and Targeted Therapy in Adjuvant NSCLC
ONE TIME EVENT
The Role of Novel Agents in Relapsed/Refractory Mantle Cell Lymphoma
ONE TIME EVENT
The Last Frontier: Metastatic Triple Negative Breast Cancer on Immunotherapy
PSMO 20TH MIDYEAR CONVENTION
Current Evidence of CDK4/6 Inhibitors in Breast Cancer Management
PSMO 20TH MIDYEAR CONVENTION
Switch from Biological to Biosimilar: Efficacy and Safety Evidences of Rituximab Biosimilar